Structures by: Suhitha S.
Total: 10
3-(4-Bromophenyl)quinazolin-4(3<i>H</i>)-one
C14H9BrN2O
Acta Crystallographica Section E (2011) 67, 11 o2928
a=16.961(3)Å b=3.9530(8)Å c=17.698(3)Å
α=90.00° β=93.168(11)° γ=90.00°
2-(4-Bromobenzoyl)-1-ferrocenylspiro[11<i>H</i>-pyrrolidizine-3,11'-indeno[1,2-<i>b</i>]quinoxaline]
C38H30BrFeN3O
Acta Crystallographica Section E (2013) 69, 9 m512-m513
a=9.3668(3)Å b=9.9785(3)Å c=18.6303(5)Å
α=89.7240(10)° β=75.9670(10)° γ=63.2360(10)°
6-Ferrocenoyl-7-phenylspiro[hexahydropyrrolo[1,2-<i>c</i>][1,3]thiazole-5,11'-indeno[1,2-<i>b</i>]quinoxaline]
C37H29FeN3OS
Acta Crystallographica Section E (2013) 69, 9 m500
a=9.5687(3)Å b=10.0175(3)Å c=17.1768(5)Å
α=80.367(2)° β=75.4300(10)° γ=65.2930(10)°
6-Ferrocenoyl-7-(4-fluorophenyl)spiro[hexahydropyrrolo[1,2-<i>c</i>][1,3]thiazole-5,11'-indeno[1,2-<i>b</i>]quinoxaline]
C37H28FFeN3OS
Acta Crystallographica Section E (2013) 69, 9 m501
a=8.7097(2)Å b=12.6456(3)Å c=13.5477(4)Å
α=83.8650(10)° β=79.0080(10)° γ=86.7760(10)°
3'-(4-Chlorobenzoyl)-4'-(4-chlorophenyl)-1'-methylspiro[indoline-3,2'- pyrrolidin]-2-one
C25H20Cl2N2O2
Acta Crystallographica Section E (2011) 67, 11 o3128
a=11.4139(2)Å b=11.6957(2)Å c=16.5262(2)Å
α=90.00° β=102.0370(10)° γ=90.00°
{1'-Phenyl-1',2',5',6',7',7a'-hexahydrospiro[indeno[1,2-<i>b</i>]quinoxaline- 11,3'-pyrrolizin]-2'-yl}(<i>p</i>-tolyl)methanone
C35H29N3O
Acta Crystallographica Section E (2012) 68, 8 o2469
a=16.4102(6)Å b=16.4371(6)Å c=20.0648(7)Å
α=90.00° β=90.00° γ=90.00°
4-[4-(4-Chlorobenzoyl)-2,3-diphenylisoxazolidin-5-yl]-1-(4-methoxyphenyl)- 3-phenylazetidin-2-one
C38H31ClN2O4
Acta Crystallographica Section E (2012) 68, 10 o2914
a=10.1221(10)Å b=17.4890(17)Å c=17.7421(18)Å
α=90.00° β=98.150(6)° γ=90.00°
11-Hydroxy-9-[1-(4-methylphenyl)-4-oxo-3-phenylazetidin-2-yl]-18-oxo-10-oxa- 2-azapentacyclo[9.7.0.0^1,8^.0^2,6^.0^12,17^]octadeca-12,14,16-triene-8- carbonitrile
C33H29N3O5
Acta Crystallographica Section E (2012) 68, 12 o3290-o3291
a=10.2874(16)Å b=14.138(3)Å c=18.866(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 12-hydroxy-10-[1-(4-methoxyphenyl)-2-oxo-3-phenoxyazetidin-4-yl]- 11-oxa-3-azahexacyclo[11.7.1.0^2,9^.0^2,12^.0^3,7^.0^17,21^]henicosa- 1(20),13,15,17(21),18-pentaene-9-carboxylate
C37H34N2O7
Acta Crystallographica Section E (2012) 68, 12 o3329-o3330
a=9.6545(11)Å b=20.363(2)Å c=31.804(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 11-hydroxy-9-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]-18-oxo-10-oxa-2-azapentacyclo[9.7.0.0^1,8^.0^2,6^.0^12,17^]octadeca-12(17),13,15-triene-8-carboxylate
C34H32N2O7
Acta Crystallographica Section E (2013) 69, 3 o438-o439
a=10.9030(5)Å b=11.8792(5)Å c=22.4457(10)Å
α=90.00° β=93.963(3)° γ=90.00°